It’s US registered fully reporting OTCQB, based out of Switzerland.
We think there are risk but worth taking bc we think it’s highly undervalued.
Market cap is currently 15 mil at .05
Some of us think the company should be valued at 10x this minimum. Their patented technology and methods are very important to vaccine manufacturing and they have many projects that are ongoing.
Some of them we believe have the potential to be blockbusters. They have been in business 20 years and have strong partnerships and connections.
My plan is to sell a small portion at much higher levels (hopefully .50 cents - 1.00), recoup my investment, and then hold the rest for a possible uplisting, buyout, or merger in the future.
$MYMX
News 
Market Data 
Discover 
